During the past decade, Pacific Research Network conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pacific Research Network" are "Age-Related Cognitive Decline" (1 trials), "Age-Related Memory Disorders" (1 trials), "Alzheimer Disease" (1 trials) and "Mild Cognitive Impairment" (1 trials). Many other conditions were trialed in "Pacific Research Network" in a lesser frequency.

Most popular intervention types in "Pacific Research Network" are "Drug" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aricept (donepezil hydrochloride)" (1 trials), "DHA (nutritional supplement) or placebo" (1 trials), "placebo" (1 trials) and "xaliproden (SR57746A)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Research Network" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Pacific Research Network". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Pacific Research Network, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Research Network, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".